P47.15 A Phase IA Study of Ceritinib + Trametinib in Patients With Advanced ALK- or ROS1- Rearranged NSCLC: Preliminary Results

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2021-10, Vol.16 (10), p.S1103-S1103
Main Authors: Lara, M., Gubens, M., Bacaltos, B., Lim, S., Li, T., Gandara, D., Riess, J., Blakely, C.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2021.08.508